Ascletis Announces Completion of First Sale of Its Ritonavir Tablets in Zhejiang Province

HANGZHOU, China and SHAOXING, China, April 4, 2022 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672) today announces that the first sale of its ritonavir tablets in Zhejiang Province has been completed. On April 3, 2022, Ascletis’ distributor, Zhejiang Int’l Medicine Co., Ltd. (“Zhejiang…

About the Author

has written 39590 stories on this site.

Copyright © 2010 Business and Corporate News.